Cryosite Limited

Equities

CTE

AU000000CTE1

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 07:08:26 03/06/2024 am IST			5-day change	1st Jan Change
1.02 ^AUD	-4.67%		-2.86%	+68.60%

22/02	Cryosite Limited Announces Board Changes	CI
22/02	Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Cryosite Ltd Announces Executive Changes

June 15, 2017 at 05:06 am IST

Cryosite Ltd. announced that Mr. Mark Byrne, CFO has been appointed Interim CEO. It has been agreed with Mr. Andrew Shine (CEO), that his notice period will now be effective June 30, 2017. The Board will commence a search immediately for a new CEO and will consider both internal and external candidates.

Latest news about Cryosite Limited

Cryosite Limited Announces Board Changes	22/02	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023	22/02	CI
Cryosite Proposes Capital Return to Shareholders	05/01	MT
Cryosite Limited Announces Director Changes	08/12	CI
Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023	24/23/24	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2023	24/23/24	CI
Cryosite Limited Appoints Luis Antonio as an Independent Non-Executive Director	17/23/17	CI
Cryosite Limited Announces the Resignation of Bryan Dulhunty as Non Executive Director	01/23/01	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/23/23	CI
Cryosite Limited Announces Change of Company Secretary	18/23/18	CI
Cryosite Limited Announces Ordinary Dividend for the Year Ended June 30, 2022, Payable on October 14, 2022	26/22/26	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26/22/26	CI
Cryosite Limited Announces Board Changes	10/22/10	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/22/23	CI
Cryosite Limited Announces Change in Company Secretary	11/22/11	CI
Cryosite Limited Appoints Steven Waller as Non-Executive Director	19/21/19	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2021	25/21/25	CI
Tranche Update on Cryosite Limited's Equity Buyback Plan announced on March 11, 2021.	18/21/18	CI
Cryosite Limited's Equity Buyback announced on March 11, 2021, has expired with 0 shares, representing 0% for AUD 0 million.	17/21/17	CI
Cryosite Limited authorizes a Buyback Plan.	11/21/11	CI
Cryosite Limited announces an Equity Buyback for 4,685,956 shares, representing 10% of its issued share capital.	11/21/11	CI
Cryosite Limited Announces Resignation of Bryan Dulhunty from Executive Chairman's Role to That of Non-Executive Chairman	15/20/15	CI
Cryosite Limited Announces the Appointment of John Hogg as Chief Executive Officer	15/20/15	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2020	28/20/28	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2019	27/20/27	CI

Chart Cryosite Limited

Duration

Period

More charts

Company Profile

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.

Sector

Healthcare Facilities & Services

Calendar

23/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CRYOSITE LIMITED	+68.60%	34.68M
HCA HEALTHCARE, INC.	+25.52%	88.99B
CVS HEALTH CORPORATION	-24.52%	74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.34%	26.63B
FRESENIUS SE & CO. KGAA	+4.81%	17.88B
LABCORP HOLDINGS INC.	-14.25%	16.43B
QUEST DIAGNOSTICS INCORPORATED	+2.97%	15.77B
TENET HEALTHCARE CORPORATION	+79.20%	13.21B
NATERA, INC.	+70.11%	13.08B
DAVITA INC.	+40.44%	12.9B

Other Healthcare Facilities & Services